To investigate the effectiveness of ACOX1-specific inhibitors combined with OCA in treating NASH, wild-type mice were fed a high-fat diet for 14 weeks to induce NAFLD. This evidence concerns the gene ACOX1 and metabolic dysfunction-associated steatotic liver disease.